Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 26 Artikel )

07.05.2019 | Review | Ausgabe 3/2019 Open Access

Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success

Marina Elena Cazzaniga, Romano Danesi, Corrado Girmenia, Pietro Invernizzi, Alessandra Elvevi, Massimo Uguccioni, NetworkER+

07.05.2019 | Review | Ausgabe 3/2019 Open Access

Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer

Michael Patrick Lux, Sarah Böhme, Stephanie Hücherig, Ulli Jeratsch, Niclas Kürschner, Diana Lüftner

11.05.2019 | Review | Ausgabe 3/2019

De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis

Arif Ali Awan, Brian Hutton, John Hilton, Sasha Mazzarello, Catherine Van Poznak, Lisa Vandermeer, Brianne Bota, Carol Stober, Marta Sienkiewicz, Dean Fergusson, Risa Shorr, Mark Clemons

13.05.2019 | Review | Ausgabe 3/2019

Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis

Motahare Pilevarzadeh, Mehrbanoo Amirshahi, Roghaiyeh Afsargharehbagh, Hosein Rafiemanesh, Seyed-Mehdi Hashemi, Abbas Balouchi

14.05.2019 | Review | Ausgabe 3/2019

Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis

John Silberholz, Dimitris Bertsimas, Linda Vahdat

03.05.2019 | Preclinical study | Ausgabe 3/2019

Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer

Evan N. Cohen, Tamer M. Fouad, Bang-Ning Lee, Banu K. Arun, Diane Liu, Sanda Tin, Angelica M. Gutierrez Barrera, Toshihide Miura, Iwao Kiyokawa, Jun Yamashita, Ricardo H. Alvarez, Vicente Valero, Wendy A. Woodward, Yu Shen, Naoto T. Ueno, Massimo Cristofanilli, James M. Reuben

07.05.2019 | Preclinical study | Ausgabe 3/2019

Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial

Carsten Denkert, Jan Budczies, Meredith M. Regan, Sibylle Loibl, Patrizia Dell’Orto, Gunter von Minckwitz, Mauro G. Mastropasqua, Christine Solbach, Beat Thürlimann, Keyur Mehta, Jens-Uwe Blohmer, Marco Colleoni, Volkmar Müller, Frederick Klauschen, Beyhan Ataseven, Knut Engels, Roswitha Kammler, Berit M. Pfitzner, Manfred Dietel, Peter A. Fasching, Giuseppe Viale

08.05.2019 | Preclinical study | Ausgabe 3/2019 Open Access

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer

Hitomi Mori, Makoto Kubo, Masaya Kai, Mai Yamada, Kanako Kurata, Hitomi Kawaji, Kazuhisa Kaneshiro, Tomofumi Osako, Reiki Nishimura, Nobuyuki Arima, Masayuki Okido, Junji Kishimoto, Yoshinao Oda, Masafumi Nakamura

03.05.2019 | Clinical trial | Ausgabe 3/2019

Efficacy of a web-based women’s health survivorship care plan for young breast cancer survivors: a randomized controlled trial

H. Irene Su, Shaylyn Stark, Brian Kwan, Sarah Boles, Diana Chingos, Jennifer Ehren, Jessica R. Gorman, Michael Krychman, Sally A. D. Romero, Jun J. Mao, John P. Pierce, Loki Natarajan

07.05.2019 | Clinical Trial | Ausgabe 3/2019

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

Hee Jun Choi, Jai Min Ryu, Isaac Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Jeong Eon Lee, Se Kyung Lee

07.05.2019 | Clinical trial | Ausgabe 3/2019

Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival

B. M. Aarts, E. G. Klompenhouwer, R. C. Dresen, A. Laenen, R. G. H. Beets-Tan, K. Punie, P. Neven, H. Wildiers, G. Maleux

08.05.2019 | Clinical trial | Ausgabe 3/2019

Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)

Christel Fontaine, Vincent Renard, Heidi Van den Bulk, Peter Vuylsteke, Philip Glorieux, Catherine Dopchie, Lore Decoster, Leen Vanacker, Evandro de Azambuja, Jacques De Greve, Ahmad Awada, Hans Wildiers

11.05.2019 | Clinical trial | Ausgabe 3/2019

Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy

Jennifer Y. Sheng, Amanda L. Blackford, Aditya Bardia, Raghunandan Venkat, Gedge Rosson, Jon Giles, Daniel F. Hayes, Stacie C. Jeter, Zhe Zhang, Jill Hayden, Anne Nguyen, Anna Maria Storniolo, Karineh Tarpinian, Norah Lynn Henry, Vered Stearns

26.02.2019 | Clinical trial | Ausgabe 3/2019

The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial

Noriko Sagawa, Shinji Ohno, Takahiro Hiratsuka, Naoto Kondo, Hiroji Iwata, Hiroko Bando, Tetsuji Ohyama, Mayumi Ishida, Yohei Kono, Kentaro Nakajima, Shinichiro Empuku, Setsuko Nishikawa, Yoshiko Irie, Masafumi Inomata, Seigo Kitano

21.05.2019 | Clinical trial | Ausgabe 3/2019

Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study

Shinji Ohno, Hirofumi Mukai, Kazutaka Narui, Yasuo Hozumi, Yasuo Miyoshi, Hiroshi Yoshino, Hiroyoshi Doihara, Akihiko Suto, Motoshi Tamura, Takashi Morimoto, Hisamitsu Zaha, Takashi Chishima, Reiki Nishimura, Takashi Ishikawa, Yukari Uemura, Yasuo Ohashi

21.05.2019 | Clinical trial | Ausgabe 3/2019

VicTORia: a randomised phase II study to compare vinorelbine in combination with the mTOR inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced HER2-negative breast cancer

Thomas Decker, Norbert Marschner, Axel Muendlein, Anja Welt, Volker Hagen, Jaqueline Rauh, Helge Schröder, Peter Jaehnig, Karin Potthoff, Christian Lerchenmüller

09.05.2019 | Epidemiology | Ausgabe 3/2019

Adult weight gain accelerates the onset of breast cancer

Maria Azrad, Cindy K. Blair, Cheryl L. Rock, Rebecca L. Sedjo, Kathleen Y. Wolin, Wendy Demark-Wahnefried

10.05.2019 | Epidemiology | Ausgabe 3/2019

Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis

Mira Goldberg, Rinku Sutradhar, Lawrence Paszat, Timothy J. Whelan, Sumei Gu, Cindy Fong, Eileen Rakovitch

13.05.2019 | Epidemiology | Ausgabe 3/2019

Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer

Yun Rose Li, Vicky Ro, Laura Steel, Elena Carrigan, Jenny Nguyen, Austin Williams, Alycia So, Julia Tchou

16.05.2019 | Epidemiology | Ausgabe 3/2019

Effects of tea consumption and the interactions with lipids on breast cancer survival

Jia-Yi Zhang, Yu-Huang Liao, Ying Lin, Qiang Liu, Xiao-Ming Xie, Lu-Ying Tang, Ze-Fang Ren

15.02.2019 | Epidemiology | Ausgabe 3/2019

Breast cancer risk in relation to plasma metabolites among Hispanic and African American women

Hua Zhao, Jie Shen, Steven C. Moore, Yuanqing Ye, Xifeng Wu, Francisco J. Esteva, Debasish Tripathy, Wong-Ho Chow

01.06.2019 | Correction | Ausgabe 3/2019

Correction to: Breast cancer risk in relation to plasma metabolites among Hispanic and African American women

Hua Zhao, Jie Shen, Steven C. Moore, Yuanqing Ye, Xifeng Wu, Francisco J. Esteva, Debasish Tripathy, Wong-Ho Chow

20.05.2019 | Epidemiology | Ausgabe 3/2019

Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy

Lynn Jongen, Giuseppe Floris, Hans Wildiers, Frank Claessens, François Richard, Annouschka Laenen, Christine Desmedt, Jan Ardui, Kevin Punie, Ann Smeets, Patrick Berteloot, Ignace Vergote, Patrick Neven

22.05.2019 | Brief Report | Ausgabe 3/2019

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy

Zahraa Al-Hilli, Grace Choong, Michael G. Keeney, Daniel W. Visscher, James N. Ingle, Matthew P. Goetz, James W. Jakub

09.05.2019 | Letter to the Editor | Ausgabe 3/2019

Microinvasion: could it be sufficient diagnostic criteria for the optimal treatment decision?

Darko Zdravkovic, Nebojsa Ivanovic, Bogdan Crnokrak

18.05.2019 | Letter to the Editor | Ausgabe 3/2019

HER2+ and triple-negative phenotypes in invasive lobular carcinoma might have different specific biological features

Kadri Altundag

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise